2 completed, 2 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Ventria Bioscience: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of rhLactoferrin on Chronic Inflammation in the Elderly rhLactoferrin, Placebo - Inflammation, Cognitive Deterioration | Phase 2 | Completed | Johns Hopkins University | 36 | 2017-08-14 | 2023-10-03 |
| Lactoferrin Treatment in HIV Patients Recombinant Lactoferrin, Placebo - HIV Infection | Phase 2 | Completed | Jason Baker | 55 | 2014-09-01 | 2024-12-31 |
| Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients Lactoferrin - Diarrhea | Phase 3 | Unknown | Ventria Bioscience | 340 | 2011-09-01 | 2011-06-27 |
| Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile. recombinant human lactoferrin - Clostridium Difficile | Not applicable | Unknown | Johns Hopkins University | 30 | 2005-10-01 | 2006-09-15 |
Diarrhea (1) · HIV Infections (1) · Inflammation (1)
Lactoferrin (1)
United States (3)
Delia Bethell, Ph.D. (1) · Jason V Baker, MD, MS (1) · Jerermy D. Walston, MD (1) · Ning Huang, Ph.D. (1) · William B Greenough, III, MD (1)
R21AG053681 (1), R44AG037211 (1)